3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
6
NIH
4
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Central Nervous System Neoplasms
38
Head and Neck Neoplasms
32
Lung Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
28
Lymphoma
27
Carcinoma, Non-Small-Cell Lung
23
Prostatic Neoplasms
21
Breast Neoplasms
18
Brain Neoplasms
18
Leukemia
15
Glioblastoma
15
Sarcoma
13
Gliosarcoma
13
Uterine Cervical Neoplasms
12
Astrocytoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Adenocarcinoma of Lung
11
Burkitt Lymphoma
10
Rhabdomyosarcoma
9
Neoplasm Metastasis
9
Lymphoma, Large B-Cell, Diffuse
9
Hodgkin Disease
9
Rectal Neoplasms
8
Radiation Injuries
8
Oligodendroglioma
8
Esophageal Neoplasms
8
Colorectal Neoplasms
8
Adenocarcinoma Of Esophagus
8
Urinary Bladder Neoplasms
6
Stomach Neoplasms
6
Interventions
Cisplatin
4
Paclitaxel
3
Docetaxel
3
Taxes
2
Radiotherapy, Conformal
2
Polymerase Chain Reaction
2
Immunohistochemistry
2
Gene Expression Profiling
2
Gemcitabine
2
Carboplatin
2
vandetanib
1
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
mercaptoundecahydrododecaborate
1
bicalutamide
1
Vorinostat
1
Triptorelin Pamoate
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Pilocarpine
1
Methotrexate
1
Irinotecan
1
In Situ Hybridization
1
Erlotinib Hydrochloride
1
Doxorubicin
1
Chemotherapy, Adjuvant
1
CP protocol
1
Biopsy
1
Amplified Fragment Length Polymorphism Analysis
1
4-boronophenylalanine-fructose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Salivary Gland Neoplasms
×
Radiotherapy
×
Clear all
NCT00084435
2012-06-14
S0217
SWOG Cancer Research Network
Phase 2
Withdrawn